Lotus Eye Hospital Q1 Results: Net profit rises 13% YoY to ₹61 lakh

2 min read     Updated on 11 Aug 2026, 10:10 AM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Lotus Eye Hospital posted a 12.6% YoY rise in net profit to ₹61.37 lakh in Q1FY27, driven by a 26.2% surge in revenue to ₹1,705.71 lakh. Pre-tax profits jumped 38.4%, but net profit growth was tempered by higher tax and finance costs. Statutory auditors Anbarasu & Jalapathi completed a limited review of the results approved by the Board on August 10, 2026.

powered bylight_fuzz_icon
47968798

*this image is generated using AI for illustrative purposes only.

Lotus Eye Hospital reported a net profit of ₹61.37 lakh for the quarter ended June 30, 2026, marking a 12.6% increase from ₹54.48 lakh in the corresponding quarter of the previous year. The Coimbatore-based eye care provider saw revenue from operations surge 26.2% to ₹1,705.71 lakh, up from ₹1,351.69 lakh in Q1FY26, signaling strong demand recovery and operational scaling in its single-segment business.

The Board of Directors approved the standalone unaudited financial results at a meeting held on August 10, 2026, pursuant to Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The results were reviewed by the Audit Committee and subjected to a limited review by the statutory auditors, Anbarasu & Jalapathi Chartered Accountants, who issued their report on the same day.

Financial Performance

Revenue growth was supported by increased patient footfall and service utilization, though operating expenses also expanded to meet the higher volume. Total income rose to ₹1,726.79 lakh from ₹1,370.45 lakh in Q1FY26. While other income declined slightly to ₹21.08 lakh from ₹18.76 lakh, the core operational revenue drove the overall top-line expansion.

Metric Q1FY27 (₹ in lakhs) Q1FY26 (₹ in lakhs) Change
Revenue from operations 1,705.71 1,351.69 +26.2%
Total Income 1,726.79 1,370.45 +26.0%
Total Expenses 1,625.44 1,297.74 +25.2%
Profit Before Tax 101.02 72.98 +38.4%
Net Profit 61.37 54.48 +12.6%

Profit before tax improved significantly by 38.4% to ₹101.02 lakh, reflecting better cost management relative to revenue growth. However, net profit growth was moderated by higher tax expenses, which stood at ₹39.65 lakh compared to ₹18.50 lakh in the prior year quarter. This included deferred tax expenses of ₹39.65 lakh, impacting the bottom-line retention.

Expense Breakdown

Operational costs scaled with revenue, with employee benefit expenses rising to ₹364.89 lakh from ₹284.38 lakh, and service expenses increasing to ₹324.82 lakh from ₹261.20 lakh. Finance costs more than quadrupled to ₹50.65 lakh from ₹11.76 lakh, likely due to new borrowings or interest rate adjustments, though this was partially offset by lower other expenses at ₹232.38 lakh versus ₹239.85 lakh. Depreciation and amortization expenses also nearly doubled to ₹163.54 lakh, indicating capital expenditure deployment.

What the Numbers Show

The divergence between the 38.4% rise in pre-tax profits and the 12.6% rise in net profit highlights the impact of tax structuring and deferred tax liabilities on final earnings. While operational efficiency improved—evidenced by total expenses growing at a similar pace to revenue—the significant jump in finance costs suggests increased leverage or debt servicing obligations that warrant monitoring in subsequent quarters. The company’s ability to maintain margin stability despite higher interest outlays demonstrates resilient core operations in the eye care segment.

Historical Stock Returns for Lotus Eye Hospital

1 Day5 Days1 Month6 Months1 Year5 Years
+4.55%+2.90%+2.19%+0.60%+65.06%+166.53%

How will the significant increase in finance costs and new borrowings impact Lotus Eye Hospital's debt-to-equity ratio and future interest coverage in upcoming quarters?

What specific expansion projects or capital expenditures drove the near-doubling of depreciation and amortization expenses, and when are these assets expected to yield ROI?

Given the divergence between pre-tax profit growth (38.4%) and net profit growth (12.6%), what strategies is management employing to optimize tax structuring and reduce deferred tax liabilities?

Lotus Eye Hospital FY26 net profit falls 89% to ₹8.04 lakh

1 min read     Updated on 06 Jun 2026, 03:06 PM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Lotus Eye Hospital and Institute Limited reported an 89.1% decline in net profit to ₹8.04 lakh for FY26, despite revenue rising 8.4% to ₹5,371.41 lakh. The Board approved the audited financial results, which received an unmodified opinion from statutory auditors M/s. Anbarasu & Jalapathi. Additionally, the Board reappointed Mr. P Vishnu Adithan as Internal Auditor for FY 2026-27.

powered bylight_fuzz_icon
42284129

*this image is generated using AI for illustrative purposes only.

Lotus Eye Hospital and Institute Limited reported a sharp decline in profitability for the financial year ended March 31, 2026, with net profit falling 89.1% to ₹8.04 lakh from ₹73.93 lakh in the previous year. The company's revenue from operations rose 8.4% to ₹5,371.41 lakh from ₹4,956.25 lakh in FY25, driven by higher operational activity. Total income for the year increased to ₹5,489.03 lakh from ₹5,086.38 lakh in the prior year.

Financial Performance

The company's expenses outpaced revenue growth, impacting the bottom line. Total expenses for FY26 increased to ₹5,493.98 lakh from ₹4,949.10 lakh in the previous year. Finance costs surged significantly to ₹85.92 lakh from ₹35.50 lakh, while depreciation and amortization expenses rose to ₹374.94 lakh from ₹300.68 lakh. For the quarter ended March 31, 2026, the company reported a net loss of ₹31.95 lakh compared to a net profit of ₹25.23 lakh in the same quarter of the previous year.

Key Financial Metrics (FY26)

Metric FY26 (₹ in lakhs) FY25 (₹ in lakhs) Change
Revenue from operations 5,371.41 4,956.25 +8.4%
Total income 5,489.03 5,086.38 +7.9%
Total expenses 5,493.98 4,949.10 +11.0%
Net profit 8.04 73.93 -89.1%
Earnings per share (Basic) 0.04 0.36 -88.9%

Board Approvals and Auditor Report

The Board of Directors approved the standalone audited financial results for the quarter and year ended March 31, 2026, at a meeting held on May 26, 2026. M/s. Anbarasu & Jalapathi, Chartered Accountants, the statutory auditors, issued an audit report with an unmodified opinion. The report confirms that the financial results give a true and fair view in conformity with the recognition and measurement principles laid down in the Indian Accounting Standards (Ind AS).

Governance and Appointments

In addition to the financial results, the Board approved the reappointment of Mr. P Vishnu Adithan, Chartered Accountant, as the Internal Auditor of the company for the financial year 2026-27. The company operates in a single segment, "Eye Care related sales and services," and does not have any subsidiaries, associates, or joint ventures.

Historical Stock Returns for Lotus Eye Hospital

1 Day5 Days1 Month6 Months1 Year5 Years
+4.55%+2.90%+2.19%+0.60%+65.06%+166.53%

What specific measures will management take to curb the surge in finance costs and depreciation expenses?

Is the 8.4% revenue growth sustainable given the recent quarterly net loss reported?

How does the company plan to improve operational efficiency to align expense growth with revenue?

More News on Lotus Eye Hospital

1 Year Returns:+65.06%